OFFICIAL PUBLICATION OF

by its subsidiary APPco

Mixed news on Vyvanse shortage

Chris Brooker 08/03/2024

There has been good, and bad, news about the ongoing shortage of the ADHD treatment The Therapeutic Goods Administration (TGA) has an update informing of mixed news about ongoing shortages of Vyvanse (lisdexamfetamine dimesilate) capsules, with a resolution achieved for one strength of the drug, while the shortage of another has been extended. In a

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Diabetes shortages targeted in report

So novo nordisk shouldn’t have applied for PBS listing then. Imagine what they could have charged!!!

Paul Sapardanis

Vape reform undermines pharmacists: PSA

... absence of a TGA-approved product... we do not abrogate our duty of care just because an item is S4.…

Wilson Tan

Vape reform undermines pharmacists: PSA

PSA president, Assoc prof Fei Sim said herself "doing nothing is not an option". She goes on to sau "not…

Wilson Tan

Diabetes shortages targeted in report

I don’t feel any regulatory burden. What I’m saying is that it shouldn’t be regulated. It works for diabetes so…

John Smith

Mixed news on Vyvanse shortage

Previous Man hurls abuse at CWH staff

Next ‘We hear and value all voices’

One organ, a multitude of benefits

Clinical tips: Timing!

Clinical tips: Movement disorders

Clinical tips: Worms, Worms, Worms

MENU

Previous Man hurls abuse at CWH staff

Next ‘We hear and value all voices’

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.